Clinical Trial Applications: Filter, Search, and view applications
| # | Protocol No | Study Title | Investigator(s) & Site(s) | |
|---|---|---|---|---|
436. |
ECCT/14/05/03 | Invivo II study Therapeutic efficacy of dihydroartemisinin piperaquine and artemether lumefantrine for the treatment of uncomplicated malaria in Kisumu County, Western Kenya Therapeutic efficacy of dihydroartemisinin piperaquine and artemether lumefantrine for the treatment of uncomplicated malaria in Kisumu County, Western Kenya |
Principal Investigator(s) 1. Ben Andagalu Site(s) in Kenya Kombewa Clinical Research Center |
View |
437. |
ECCT/14/05/02 | Invivo I study In vivo and in vitro efficacy of artemisinin combination therapy in Kisumu County, Western Kenya. |
Principal Investigator(s) 1. Ben Andagalu Site(s) in Kenya Kombewa Clinical Research Center |
View |
438. |
ECCT/14/04/01 | REACH Trial REALIZING EFFECTIVENESS ACROSS CONTINENTS WITH HYDROXYUREA (REACH): A PHASE I/II PILOT STUDY OF HYDROXYUREA FOR CHILDREN WITH SICKLE CELL ANAEMIA. |
Principal Investigator(s) 1. Thomas Neil Williams Site(s) in Kenya Kilifi County Hospital |
View |
439. |
ECCT/14/03/02 | Rivaroxaban on prevention of stroke and non-central nervous system systemic embolism in patients with non valvular atrial fibrillation XANTUS-EL, Xarelto on prevention of stroke and non-central nervous system systemic embolism in patients with non valvular atrial fibrillation - a non interventional study, XA 1206 (IMPACT No. 16691) |
Principal Investigator(s) 1. Warshow Majid Mbarak Site(s) in Kenya 1. MP Shah Hospital (Nairobi City county) |
View |
440. |
ECCT/14/03/01 | Comparison of School and Community-based Mass Drug Administration Delivery Strategies for Control of Schistosoma mansoni Infections in Western Kenyan in Areas with > 25% Prevalence |
Principal Investigator(s) 1. Mwinzi Ngina Mwinzi Site(s) in Kenya Nyanza region |
View |